PharmaRoth Labs, Inc. focuses on diabetes prevention and treatments. It holds the intellectual property rights related to the production, marketing and distribution of Sucanon, a oral treatment for type II diabetes. The company was founded on December 11, 2000 and is headquartered in Las Vegas, NV.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company